Nanoparticles for monoclonal antibody delivery

Details Nanoparticles for monoclonal antibody delivery Nanoparticles for monoclonal antibody delivery

2006-05-12

2009-06-02

Desai, Anand U (Department: 1656)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C977S733000, C977S915000, C514S002600

Reexamination Certificate

active

07541028

ABSTRACT:
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent of monoclonal antibody. The nanoparticles are characterized with a positive surface charge and their enhanced permeability for paracellular drug delivery.

REFERENCES:
patent: 5851579 (1998-12-01), Wu et al.
patent: 6165440 (2000-12-01), Esenakiev
patent: 6383478 (2002-05-01), Prokop et al.
patent: 6555376 (2003-04-01), Maitra et al.
patent: 6649192 (2003-11-01), Alonso Fernandez et al.
patent: 6689338 (2004-02-01), Kotov
patent: 7067144 (2006-06-01), Demopulos et al.
patent: 7282194 (2007-10-01), Sung et al.
patent: 2002/0197256 (2002-12-01), Grewal
patent: 2008/0213354 (2008-09-01), Sung et al.
Lin YH et al., “Preparation of nanoparticles composed of chitosan/poly-r-glutamic acid and evaluation of their permeability through Caco-2 cells” Biomacromolecules 2005;6:1104-1112.
Rosa GD et al. “Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres” J Control. Release 2000;69:283-295.
Pan Y et al. “Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo” Int J Pharma 2002;249:139-147.
Xiong XY et al., “Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles” J Control. Release 2005;103:73-82.
Product Information “Humira” by Abbott Laboratories, North Chicage, Illinois, Oct. 2005.

Affiliated with

Also associated with

Rating

Nanoparticles for monoclonal antibody delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nanoparticles for monoclonal antibody delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticles for monoclonal antibody delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4083963